Successfully obtained in the EU CE access certification

Passed ISO13485 certification

Respiratory tract infections are divided into upper respiratory tract infections and lower respiratory tract infections. Upper respiratory tract infections mainly manifest as fever, headache, tinnitus, cough, runny nose, nasal congestion, etc., and are dominated by viruses, accounting for 70% to 80%. Lower respiratory tract infections include pneumonia, tracheitis, bronchitis, capillary bronchitis, etc. Usually, lower respiratory tract infections are much more serious than upper respiratory tract infections, and the pathogens are more complex.

Acute upper respiratory infections occur in most people every year, 2 to 4 times per year in adults and in children at a higher rate of 6 to 8 times per year

Clinical significance: 

• Early Identification
  

Direct detection of pathogens, shorten pathogen reporting time, improve the pathogen detection rate, and improve detection of mixed infections

• Precise treatment

Timely and accurate pathogenic results can promote the rational use of antibacterial drugs, facilitate infection control, and improve patient prognosis

• Conserve medical resources

Optimize the treatment process, shorten hospital stays, and reduce treatment costs, resulting in clinical and economic benefits

• Epidemic prevention and control

Screening and early warning of respiratory diseases, helping to normalize epidemic prevention and control, reducing the spread of respiratory diseases and infections in groups